PATENT CLAIM ANALYSIS

Application Number: 15986186
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-10
Patent Classification: ["424", "498000"]

Abstract:
Embodiments disclosed herein relates to ganglioside GM3-containing mixed lipids nanoparticles having an overall size between 60-100 nm, the making thereof and the uses. The nanoparticles selectively targeted to CD169+ expressing cells such as dendritic cells and macrophage. The nanoparticles are endocytosed by the CD169+ expressing cells.

Claim (Index 5):
The nanoparticle of  claim 1 , wherein the coating layer is a thiolated lipid, a silane with long alkyl chains, or polyethylene glycol thiol.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 93.0
- Lexical Diversity: 1.35135
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15304127', '14366839', '12428381', '12966070', '14186881']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6836079648225895
- 35 USC 102 Novelty (BERT): 0.6850464319730748
- Combined Prediction Score: 0.683751811537638
- Mean Citation Score: 305.83204400000005
- Max Citation Score: 678.4343
- Similarity Product: 672.6594940321863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test